(Q49576515)

21 February 2018

review article

1 reference

title

Diagnosis and management of Lyme neuroborreliosis. (English)

1 reference

21 February 2018

0 references

John J Halperin

1

0 references

publication date

26 December 2017

1 reference

21 February 2018

Expert Review of Anti-infective Therapy

published in

1 reference

21 February 2018

volume

16

1 reference

21 February 2018

issue

1

1 reference

21 February 2018

page(s)

5-11

1 reference

21 February 2018

Lyme neuroborreliosis-epidemiology, diagnosis and management

cites work

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1417836

Prediction of Lyme meningitis based on a logistic regression model using clinical and cerebrospinal fluid analysis: a European study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1417836

Prospective validation of a clinical prediction model for Lyme meningitis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1417836

The chemokine CXCL13 is a key regulator of B cell recruitment to the cerebrospinal fluid in acute Lyme neuroborreliosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1417836

Course and Outcome of Early European Lyme Neuroborreliosis (Bannwarth Syndrome): Clinical and Laboratory Findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1417836

Peripheral neuropathy in acrodermatitis chronica atrophicans (Herxheimer)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1417836

A critical appraisal of the mild axonal peripheral neuropathy of late neurologic Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1417836

Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1417836

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1417836

Chronic neurologic manifestations of erythema migrans borreliosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1417836

EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1417836

Two-Tiered Antibody Testing for Lyme Disease With Use of 2 Enzyme Immunoassays, a Whole-Cell Sonicate Enzyme Immunoassay Followed by a VlsE C6 Peptide Enzyme Immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1417836

Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1417836

Practice Parameter: Treatment of nervous system Lyme disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1417836

The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14787210.2018.1417836

10.1080/14787210.2018.1417836

21 January 2018

Identifiers

DOI

1 reference

21 February 2018

PubMed ID

29278020

1 reference

21 February 2018